Young gay men and the quadrivalent human papillomavirus vaccine--much to gain (and lose).

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Sexual network and detection of anogenital human papillomavirus in a community cohort of men who have sex with men in Taiwan.PloS one · 2019
   Trial
2. Factors Related to HPV Vaccination Intention among MSM in China: A Bayesian Network Model.International journal of environmental research and public health · 2022
   Article
3. Predicting human papillomavirus vaccine uptake in men who have sex with men the influence of vaccine price and receiving an HPV diagnosis.BMC public health · 2022
   Article
4. Perspectives and preferences for a mobile health tool designed to facilitate HPV vaccination among young men who have sex with men.Human vaccines & immunotherapeutics · 2019
   Article

Corrections and comments

• Comment on
  Early acquisition of anogenital human papillomavirus among teenage men who have sex with men.2014

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as